Very low bleeding rates with local thrombolytic therapy given during percutaneous endovenous intervention for the treatment of deep venous thrombosis

2011 ◽  
Vol 12 (3) ◽  
pp. e2
Author(s):  
Mohsen Sharifi ◽  
Curt Bay ◽  
Tariq Niazi ◽  
Farnaz Emrani ◽  
Farnoosh Rahimi ◽  
...  
1997 ◽  
Vol 8 (3) ◽  
pp. 405-418 ◽  
Author(s):  
Haraldur Bjarnason ◽  
Janice R. Kruse ◽  
David A. Asinger ◽  
Gwen K. Nazarian ◽  
Charles A. Dietz ◽  
...  

JAMA ◽  
1999 ◽  
Vol 282 (22) ◽  
pp. 2164 ◽  
Author(s):  
McDonald K. Horne III

2008 ◽  
Vol 100 (12) ◽  
pp. 1084-1088 ◽  
Author(s):  
Jasper H. Smalberg ◽  
Manon V. M. C. W. Spaander ◽  
Kon-Siong G. Jie ◽  
Peter M. T. Pattynama ◽  
Henk R. van Buuren ◽  
...  

SummaryTranscatheter local thrombolytic therapy in patients with acute, extended splanchnic venous thrombosis is controversial. Here we present our single-center experience with transcatheter thrombolytic therapy in these patients. All consecutive patients (n=12) with acute,extended splanchnic venous thrombosis who underwent transcatheter thrombolytic therapy in our hospital, were included in this study. Thrombolytic therapy was successful for three thrombotic events and partially successful for four thrombotic events.Two patients developed minor procedure-related bleeding (17%).Six patients (50%) developed major procedure-related bleeding, with a fatal outcome in two. Transcatheter thrombolytic therapy in patients with acute, extended splanchnic vein thrombosis is found to be associated with a high rate of procedure-related bleeding. Therefore, thrombolysis should be reserved for patients in whom the venous flow cannot be restored by using conventional anticoagulant therapy or stent placement across the thrombosed vessel segment.H.L.A. Janssen and F.W.G. Leebeek are both Clinical Fellows of the Netherlands Organisation for Scientific Research (NWO).


1993 ◽  
Vol 8 (3) ◽  
pp. 115-129 ◽  
Author(s):  
William R. Bell ◽  
Michael B. Streiff

The second part of this comprehensive review of thrombolytic therapy in clnical medicien focuses on its use in a wide renge of thrombotic disorders, including pulmonary embolism, deep venous thrombosis, arterial thrombocmbolism, catheter-related thrombosis, arterial thrombocmbolism, catheter-relted thrombosis, and prosthetic valve occlusion. New experimental applications in the management of unstable angina and cerebrovascular disease are also discussed.


Sign in / Sign up

Export Citation Format

Share Document